HEALTHCAP IX ADVISOR AB
HEALTHCAP IX ADVISOR AB is a Seed, Series A, Series B and Series C+ fund in Global and nordic writing $3.9M–$124M checks into Healthcare and pharma.
- Stages
- Seed, Series A, Series B, Series C+
- Sectors
- Healthcare, pharma
- Check size
- $3.9M–$124M
- Invests in
- Global, nordic
- Actively investing
- Yes
- Founded
- 1996
- Assets under management
- > €1.2B
Thesis
HealthCap IX Advisor AB is a European venture capital firm founded in 1996, specializing in global life sciences investments. Their core thesis focuses on precision medicine and transformative therapies for diseases with high unmet medical needs, including rare diseases, oncology, and genetic disorders. They invest across seed, Series A, Series B, and growth equity stages, with previous Series A investments ranging from $3.9M to $124M. The firm has a strong presence in the Nordic region and recently established a hub in Copenhagen. HealthCap IX secured €48 million in April 2025, and the firm has previously raised over €1.2 billion across eight funds, with total committed capital exceeding €1 billion as of 2023.
Common questions
Does HEALTHCAP IX ADVISOR AB invest at the Seed stage?
Yes. HEALTHCAP IX ADVISOR AB lists Seed, Series A, Series B and Series C+ among the stages it invests in.
What check size does HEALTHCAP IX ADVISOR AB write?
HEALTHCAP IX ADVISOR AB writes $3.9M–$124M checks.
Where does HEALTHCAP IX ADVISOR AB invest?
HEALTHCAP IX ADVISOR AB invests in Global and nordic.